NCT00105586View on ClinicalTrials.gov

Drug Therapy for Generalized Anxiety Disorder Among the Elderly

PHASE4CompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

April 30, 2008

Conditions
Anxiety DisordersGeneralized Anxiety Disorder
Interventions
DRUG

Escitalopram

Participants will either take 10 to 20 mg of escitalopram or placebo. Participants who wish to participate in the open-label extension receive an additional 12 weeks of escitalopram.

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pittsburgh

OTHER

NCT00105586 - Drug Therapy for Generalized Anxiety Disorder Among the Elderly | Biotech Hunter | Biotech Hunter